Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance

At Novavax’s 2026 Annual Meeting, nearly half of shareholders opposed the executive compensation package and there was strong opposition to three Board nominees, prompting its largest shareholder, Shah Capital, to publicly call out management’s operational shortcomings and demand urgent change. This unusually high level of shareholder pushback shines a light on governance and execution concerns that now sit alongside the company’s scientific and commercial priorities. With this backdrop of...
TSX:NXE
TSX:NXEOil and Gas

NexGen Energy (TSX:NXE) Is Down 7.6% After Advancing AI-Enabled Rook One Uranium Project Approval - What's Changed

NexGen Energy recently advanced construction of its Rook One uranium project in Saskatchewan, billed as the world’s largest uranium development and now permitted after a decade-long approval process. The company aims to leverage artificial intelligence to streamline mine construction and operations, targeting minimal human presence below the surface in early production phases. We’ll now explore how Rook One’s scale and AI-enabled mine design shape NexGen Energy’s investment narrative for...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Could Be 58% Undervalued After BlueBird Launch Plans And Japan Venture

AST SpaceMobile (ASTS) is back in focus after announcing plans to launch its BlueBird 11, 12, and 13 satellites in early August, alongside a new direct-to-mobile joint venture in Japan. See our latest analysis for AST SpaceMobile. Despite the satellite launch cadence and new joint ventures, AST SpaceMobile’s share price has been volatile. The 1-day share price return was 8.88% after recent news, the 30-day share price return was down 44.87%, and the 1-year total shareholder return was 44.75%...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK) Stock After Recent 11% Pullback Is The Valuation Now Attractive?

With BlackRock trading at a last close of US$964.71, many investors are asking a simple question: is the stock pricing in too much optimism, or is the current level still reasonable value for the long term. Over the past week the share price declined 8.1%, adding to a 9.9% fall over the last month and an 11.1% decline year to date, even though the 3 year return sits at 49.5% and the 5 year return at 21.8%. Recent news around BlackRock has focused on its role as a major global asset manager...
NYSE:NBR
NYSE:NBREnergy Services

Can Nabors (NBR) Turn Stable Rig Demand Into a More Durable Earnings Narrative?

Nabors Industries has recently benefited from steady drilling demand and rising rig day rates in the Lower 48, helped by softer crude prices following an interim US–Iran deal and restored oil flows through the Strait of Hormuz. This combination of stable rig activity and improving day-rate economics highlights how Nabors can potentially gain even when headline oil prices soften. Next, we’ll examine how firmer rig demand and higher day rates could influence Nabors Industries’ existing...
NYSE:LHX
NYSE:LHXAerospace & Defense

What L3Harris Technologies (LHX)'s Expanded PAC‑3 Propulsion and German Comms Orders Mean For Shareholders

L3Harris Technologies recently broke ground on two additional facilities at its Arkansas Advanced Propulsion Facilities campus to expand PAC-3 missile propulsion production capacity, while also securing two Foreign Military Sales orders to supply Falcon communication systems for Germany’s D‑LBO program and special operations forces. Together, the enlarged U.S. missile propulsion footprint and new German communications orders highlight how L3Harris is deepening its role in advanced defense...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Draws Fresh Attention, Is The Valuation Gap Too Wide?

Crinetics Pharmaceuticals (CRNX) has attracted fresh attention after recent trading moves, prompting investors to reassess how its clinical-stage pipeline and current share performance might align with individual risk tolerance and time horizon. See our latest analysis for Crinetics Pharmaceuticals. Recent trading has been choppy for Crinetics Pharmaceuticals, with a 1 day share price return of 4.89% and a 90 day share price return of 9%, while the year to date share price return has declined...
HLSE:ELISA
HLSE:ELISATelecom

Elisa Oyj (HLSE:ELISA) Gains Attention Following MasOrange Deal As Bearish Fair Value Lingers

MasOrange deal puts Elisa Oyj’s Polystar unit in focus Elisa Oyj (HLSE:ELISA) is back on investors’ radar after MasOrange selected its Polystar unit to provide a unified analytics and network probe solution, including AI based anomaly detection for mobile network performance. See our latest analysis for Elisa Oyj. For context, Elisa Oyj’s share price is €37.32, with the 30 day share price return down 10.37% and the 90 day share price return down 11.56%. The 1 year total shareholder return has...
XTRA:BMW
XTRA:BMWAuto

BMW (XTRA:BMW) Issues Profit Warning And Plans Job Cuts After China Weakness

BMW issued a profit warning and cut its earnings outlook as it grapples with the impact of the Iran conflict and softer demand in China. The company plans a global workforce reduction, signaling a material shift in cost priorities across its operations. These moves come as BMW faces a weaker share price backdrop and rising competition in key markets. At a share price of €59.22, XTRA:BMW has faced a difficult run, with the stock down 23.1% over the past month and 38.5% year to date. Over 3...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

How FDA Clearance of BEAM-304’s Platform Trial for PKU May Impact Beam Therapeutics (BEAM) Investors

Beam Therapeutics announced in June 2026 that the FDA cleared its IND application for BEAM-304, an in vivo base-editing therapy delivered via intravenous lipid nanoparticles to treat phenylketonuria (PKU) by correcting mutations in the PAH gene. A distinctive element of this program is Beam’s platform-style trial design, which aims to test multiple mutation-specific base editors for PKU within a single clinical framework, reflecting the FDA’s emerging guidance to accelerate genome-editing...
NasdaqCM:ZENA
NasdaqCM:ZENASoftware

Is ZenaTech (ZENA) Undervalued After Its Green Earth Deal And Zoo Office Launch?

ZenaTech (NasdaqCM:ZENA) is back on investor radars after acquiring Florida based Green Earth Powerwashing and outlining Zoo Office, an AI powered productivity platform that broadens its reach across drone services and enterprise software. See our latest analysis for ZenaTech. The recent acquisition of Green Earth Powerwashing and the Zoo Office announcement have coincided with short term momentum in ZenaTech, with a 1 day share price return of 11.43% and a 7 day share price return of 9.86%...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Is Axsome Therapeutics (AXSM) Using Solriamfetol’s Phase 3 ADHD Trial To Redefine Its CNS Strategy?

Axsome Therapeutics has recently dosed the first patient in its FOCUS-3 Phase 3, randomized, double-blind, placebo-controlled trial of solriamfetol in adolescents aged 12 to under 18 years with ADHD, assessing six-week changes in ADHD-RS-5 total scores across approximately 468 participants. This study extends solriamfetol’s development beyond sleep-related conditions into adolescent ADHD, underlining Axsome’s push to broaden its CNS treatment footprint across multiple indications. We’ll now...
NYSE:RAMP
NYSE:RAMPSoftware

How LiveRamp’s Adobe GenStudio Integration At LiveRamp Holdings (RAMP) Has Changed Its Investment Story

On 23 June 2026, LiveRamp announced a new integration with Adobe GenStudio for Commerce Media Networks, bringing commerce purchase data into Adobe’s agentic content supply chain to help brands build and launch more targeted campaigns. The integration allows commerce media networks to form cohorts based on real purchase behavior and pair them with tailored, AI-generated creative, moving brands away from modeled audiences toward campaigns shaped by what customers have actually bought. Next,...
NasdaqGS:PPC
NasdaqGS:PPCFood

How Investors May Respond To Pilgrim's Pride (PPC) Earnings Hit From Weak Margins And Free Cash Flow

Pilgrim's Pride recently reported softer quarterly results, highlighting sluggish long-term revenue growth, low gross margins, and a shrinking free cash flow margin that point to pressure on its underlying profitability. Analysts now expect a very large year-over-year earnings decline despite only modest revenue growth, suggesting that input costs, competition, and capital intensity are weighing more heavily on the business than previously assumed. We’ll now examine how concerns over weak...
NasdaqGS:APP
NasdaqGS:APPSoftware

Does Slower Axon Adoption and Insider Selling Change The Bull Case For AppLovin (APP)?

In recent days, AppLovin has faced mixed reactions as analysts flagged slower-than-expected e-commerce client adoption for its Axon platform and insider share sales, even as the company continues to roll out new advertising tools and products. This tension between cautious near-term sentiment and an expanding AI-driven advertising suite with strong operating efficiency is now a central focus for investors assessing AppLovin’s trajectory. We’ll now examine how concerns about slower Axon and...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Stock After 127% One-Year Surge Is It Too Late To Buy?

If you are wondering whether ATI is still attractively priced after a strong run, the starting point is understanding what the current market price is really reflecting. The stock recently closed at US$197.40, with returns of 16.2% over the past month, 65.6% year to date and 127.4% over the last year, while the past three years show a 346.3% gain and the past five years a very large increase. Recent coverage has focused on ATI's share price performance and how investor expectations have...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

QUALCOMM (QCOM) Is Down 16.2% After Modular Deal And AI CPU Push - Has The Bull Case Changed?

Earlier this week, Qualcomm Technologies announced an expanded collaboration with Hugging Face, launched its Dragonfly C1000 data center CPU and High Bandwidth Compute architecture, and confirmed a roughly US$3.90 billion all‑stock acquisition of AI software firm Modular to build a full-stack AI infrastructure platform from devices to the cloud. Taken together, these moves shift Qualcomm’s centre of gravity beyond smartphones toward AI data centers and developer ecosystems, positioning its...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

How Investors May Respond To Cognex (CGNX) AI Machine Vision Push And Stronger Analyst Conviction

Cognex Corporation recently presented at Automate 2026 in Chicago, where President and CEO Matthew Moschner highlighted the company’s latest AI-enabled machine vision innovations. At the same time, multiple research firms and institutional investors have cited Cognex’s AI-driven tools and better-than-expected margins as key reasons for their increasingly positive stance on the business. Now we’ll examine how this stronger analyst conviction around Cognex’s AI-powered machine vision...
NYSE:CAG
NYSE:CAGFood

Is Conagra Brands’ (CAG) High-Protein Push Quietly Redefining Its Margin and Brand Power Story?

Earlier this month, Conagra Brands rolled out a wide range of new frozen and grocery products across key labels such as Banquet, Healthy Choice, and Marie Callender’s, emphasizing high-protein recipes, convenience, and value pricing to match shifting eating habits. This concentrated push into nearly shelf-ready meal solutions, including GLP-1 “On Track” offerings, shows how Conagra is trying to reposition its core brands around current dietary patterns without abandoning its mass-market...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

What Meta Platforms (META)'s Qualcomm AI CPU Deal Means For Shareholders

Qualcomm Technologies and Meta recently announced a multi-generation collaboration under which Qualcomm’s Dragonfly C1000 data center CPUs are planned to power Meta’s next-generation AI-focused server fleet starting in the second half of 2028 and in future capacity expansions. This move highlights Meta’s effort to diversify its AI compute stack beyond GPUs and potentially improve performance per watt and total cost of ownership across its hyperscale infrastructure. We’ll now examine how...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Is Sirius XM Holdings (SIRI) Fairly Valued As Growth Concerns Persist?

Recent trading in Sirius XM Holdings (SIRI) has been shaped by investor concerns around weak long term revenue growth, soft free cash flow projections, and a declining return on invested capital, despite the stock’s recent strength. See our latest analysis for Sirius XM Holdings. At a share price of US$28.35, Sirius XM Holdings has delivered a 24.12% 90 day share price return and a 38.23% year to date share price return, while the 5 year total shareholder return is down 48.69%. This suggests...